A.R.T. Advisors’s Insmed INSM Stock Holding History

A.R.T. Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-22,177	Closed	-$568K	–	1560
2019 Q2	$568K	Buy	22,177 +1,000	+5%	+$27.9K	0.03%	702
2019 Q1	$616K	Buy	+21,177	New	+$549K	0.04%	670
2017 Q3	–	Sell	-59,382	Closed	-$1.02M	–	1488
2017 Q2	$1.02M	Buy	59,382 +9,968	+20%	+$170K	0.05%	515
2017 Q1	$865K	Buy	+49,414	New	+$762K	0.04%	611
2016 Q3	–	Sell	-30,671	Closed	-$302K	–	882
2016 Q2	$302K	Buy	+30,671	New	+$358K	0.02%	966
2015 Q4	–	Sell	-52,490	Closed	-$974K	–	1583
2015 Q3	$974K	Buy	+52,490	New	+$1.31M	0.04%	634
2014 Q4	–	Sell	-10,616	Closed	-$138K	–	1530
2014 Q3	$138K	Buy	+10,616	New	+$160K	0.01%	1172
2014 Q1	–	Sell	-20,389	Closed	-$346K	–	1435
2013 Q4	$346K	Sell	20,389 -56,515	-73%	-$865K	0.02%	924
2013 Q3	$1.2M	Sell	76,904 -45,210	-37%	-$574K	0.07%	439
2013 Q2	$1.46M	Buy	+122,114	New	+$1.25M	0.05%	490

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

A.R.T. Advisors's INSM Position: Q3 2019 in Review

A.R.T. Advisors sold out of Insmed (INSM) in Q3 2019, closing a stake of 22,177 shares — an estimated $568K sold.

A.R.T. Advisors first reported a position in INSM in Q2 2013 and held it in 10 quarters. The position peaked at $1.46M in Q2 2013. 157 funds tracked by Wall St. Rank hold INSM as of Q3 2019.

A.R.T. Advisors reported no remaining Insmed position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 22,177 Insmed shares in Q3 2019, an estimated $568K.
A.R.T. Advisors first reported a position in Insmed in Q2 2013 and held it in 10 quarters.
A.R.T. Advisors's Insmed position peaked at $1.46M in Q2 2013.
157 funds tracked by Wall St. Rank held Insmed as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.